Has Khanh Truong received payments from drug or device companies?

Yes. Drug and device makers reported $10,343 in general payments to Khanh Truong across 153 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khanh Truong did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khanh Truong come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khanh Truong

Sleep Medicine · Plano, TXNPI 1023637550

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,130 of the $10,343 with a category attached, or 78.6%. 21 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 38.1% of the total. 2025 is the largest year on record at $4,938, more than ten times the $115 reported in 2021.

$10,343in general payments, 2019–2025

Across 153 payments — averaging $67.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$4K
GSK$813
Jazz Pharmaceuticals Inc.$807
AstraZeneca$806
Novo Nordisk$589
Itamar Medical Inc$544
plus $3K from 15 others

What the payments were for

Travel & lodging$2,16821%
Food & beverage$8,13079%
Education$450%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	37	$3,938
GSK	9	$813
Jazz Pharmaceuticals Inc.	8	$807
AstraZeneca	16	$806
Novo Nordisk	12	$589
Itamar Medical Inc	2	$544
Lilly USA, LLC	9	$541
Amgen	13	$422
Pfizer	4	$253
AbbVie	8	$251
Idorsia Pharmaceuticals US Inc	3	$244
Viiv Healthcare Company	4	$244
Bayer	8	$232
Boehringer Ingelheim	10	$215
Dexcom, Inc.	2	$164
Kowa Pharmaceuticals America, Inc.	1	$117
Exact Sciences	3	$52
Harmony Biosciences LLC	1	$45
3b Medical, Inc.	1	$27
Heartflow, Inc.	1	$23
Azurity Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,343 in reported general payments places this provider in the 85th percentile of 112 sleep medicine providers in Texas.

See all sleep medicine providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate	17	$157
Amlodipine Besylate	15	$94
Atorvastatin Calcium	14	$90

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Plano

Michael KellamPlano$10K
Gerard MeskillSugar Land$1M
Vikas JainFrisco$673K
Amit VermaHouston$493K
Jerald SimmonsHouston$165K
James AndrySan Antonio$100K
William BurkesBeaumont$99K
Ashwin GowdaAustin$71K
John DebusDallas$38K
Peter ObessoTyler$34K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →